News

CAVITAT MEDICAL TECHNOLOGIES, INC. ANNOUNCES TODAY THAT IT IS BREAKING GROUND ON ITS NEW WORLD HEADQUARTERS CAMPUS IN EMORY, TEXAS. CAVITAT HAS ENTERED INTO A LONG TERM COMMITMENT WITH EMORY DEVELOPMENT COPORATION TO BRING ITS INTERNATIONAL MANUFACTURING, RESEARCH AND DEVELOPMENT TO THIS NORTHEAST TEXAS CITY. THIS MOVE WILL BRING ENGINEERING AND MEDICAL DEVICE MANUFACTURING TYPE JOBS TO THIS AREA. HIGH TECHNOLOGY JOBS HELP BRING ECONOMIC GROWTH.

CAVITAT MEDICAL TECHNOLOGIES, INC. IS THE WORLDS LEADING DEVELOPER OF SONOGRAPHIC BONE IMAGING SYSTEMS. NEW RESEARCH INTO THIS TECHNOLOGY HAS LED TO DEVELOPMENT OF SEVERAL NEW MEDICAL DEVICES BY CAVITAT'S FOUNDER BOB JONES AND FURTHER SCIENTIFIC RESEARCH WILL BEGIN FOR THE FDA CLEARANCE PROCESS.THE CAVITAT ULTRASONOGRAPH OBTAINED FDA CLEARANCE IN FEBRUARY 2002 AND IS APPROVED BY HEALTH CANADA AND IS € APPROVED FOR SALE AND USE IN EUROPE.

CAVITAT MEDICAL TECHNOLOGIES,INC. IS DEDICATED TO BRINGING MORE ADVANCED NON -INVASIVE MEDICAL DEVICES INTO A RAPIDLY COLLAPSING HEALTH CARE SYSTEM IN THE USA TO HELP LOWER MEDICAL COST FOR THE PUBLIC. CAVITAT IS PROUD TO BE A PART OF EMORY DEVELOPMENT COMMISSIONS DEDICATION TO ECONOMIC GROWTH AND JOB OPPORTUNITIES FOR THE LOCAL PUBLIC.

06/19/2006 Emory, Texas

Bob Jones, CEO of CAVITAT Medical Technologies, Inc announced today a major breakthrough in diagnostic devices. A device using digital occilloscope technology developed by Bob Jones and CAM/D LLC for CAVITAT has proven, in independent clinical trials in offshore testing, to be capable of accurately and safely imaging the resonant footprint (or frequency) and identifying all known pathogens including bacteria, virus and mycoplasma resonant frequencies. An accuracy in excess of 99.9% has been determined with non-invasive testing for the first time in medical history. The computerized system uses a finger clip much like a blood oxygen meter but is an extremely sensitive "Listening Technology". The computer system prints and displays the frequencies of any pathogens that might be present in the bloodstream or cell structure. The scan only takes 3 minutes compared to hours or days in culture samples. Units should be available in the USA by early 2007. IRB test units for FDA clearance will be produced in the next few months in the Emory Texas Facility.

06/26/2006

CAVITAT accurately defines abnormal bone in the jaw which may be ischemic and which may contribute to the recently identified problem of Bisphosphonate bone density enhancement drugs such as Fosamax (Fosamax is a registered trademark of Merck) long before the condition can be determined by the medical or dental profession without the "Ultrasonograph" produced by this manufacturer. Certain elements in our society would prefer this information remain unknown. Conditions of the jaw can be directly related to clotting factors, infections, and or drug reactions. CAVITAT first determined there was a problem with "phossy jaw" several years ago and our Scientific Advisory Board was apprising the FDA and the drug manufacturers they had a potential problem. Early detection of ischemic bone would give doctors a clue as to whether bone density drugs (Bisphosphonates) should be prescribed for use in Cancer treatment or for osteoporotic bone enhancement. As there is no known "cure" or Treatment for the advanced condition of "phossy jaw", knowing that the patient may have osteonecrosis and clotting factors before prescribing might help in deterring this progressively serious condition. Endodontic therapy seems to be related to bone loss and atypical bone which may be ischemic. Having this condition, the addition of the Bisphosphonate class of drugs like Fosamax would seem to exacerbate the condition. Early detection with a CAVITAT scan before prescribing this class of drug is suggested and should be a requirement before prescribing Bisphosphonates.

05/03/2007

Pennsylvania Court and State Dental Board dismiss all actions taken against DR. Steve Evans now practicing in Texas. DR Evans was charged with improper actions outside the accepted dental protocols. The PA Board of Dental Examiners acting on Court orders dismissed all charges against Dr. Evans proclaiming he was within the Standard of Care in performing NICO surgery and using the CAVITAT Ultrasonograph to produce a 3D image of the suspected sites. The Dental Board also set the Standard of Care for use of the FDA cleared device and its use for producing images of the Alveolar process as was the intended use. This is a major setback for organized dentistry, the Quackwatch morons, and certain Insurance companies who using a QW web posting by DR's Dodes and Schissel unresearched or unpublished opinion paper as their guideline for not paying for "NICO" surgery. certainly there will be more class action suits by patients denied claims. For more information see the full transcripts of the decisions by the PA board and Courts. **Link coming soon****

01/29/2008

We at CAVITAT have been under siege as some of you have been the past three years. Long before we filed suit against AETNA, Inc., the state dental boards were harassing and intimidating dentists that were performing NICO or cavitation surgery. Thus, in an effort to protect the cash cow of endodontic therapy performed under premise of saving a tooth this assault is ocurring. Development of the CAVITAT absolutely struck fear in their hearts. The Quackwatch and their organized assault on the integrity of the CAVITAT and the inventor is nothing short of RICO and will be pursued as such by the management of CAVITAT. The liars for hire, Robert Baratz, M.D. and Stevie "Wonder" Barrett, M.D., will be held responsible for their reckless pursuit of the destruction of the good name of CAVITAT and Bob Jones. Several federal laws and numerous state laws have been confirmed by legal advisors as having been broken by these common criminals. For those of you who don't know, AETNA's counter suit was totally dismissed on all 96 counts of conspiracy to commit insurance fraud with prejudice in January '05. Also, the claims that CAVITAT patents were invalid were dismissed, as were the claims that we intimidated the FDA to gain our 510k clearance. The Honorable Federal Judge Krieger basically said there was absolutely no evidence to support any of their claims against CAVITAT. We chose not to take action against AETNA because the judge ordered a negotiated settlement under the direction of Magistrate Judge Haggerty of the Colorado Federal Court. We were to be protected from this type of assault under severe penalties that compelled both parties and their agents to a non-defamation and slander clause WHICH ALSO INCLUDED THE QW DOCTORS AS AETNA'S ADMITTED AGENTS. This clause has been broken by QW 29 times in writing on the web alone.

The CAVITAT was proven to be accurate at more that 99.99% in all cases totaling over 3,742 patients in more than 2 peer reviewed studies. One published in "Cranio" and the other in "Journal of Oral Pathology". Comparing the CAVITAT to X-Ray and enhanced MRI, the CAVITAT was more than 2 times as accurate than the MRI and 3 times more accurate than X-ray. QW's Mark Probert states he has evidence to the contrary. Here is our challenge: Where is this evidence, Mark? You cannot produce it, as it does not exist. So, YOU have also been named in front of the grand jury. The CAVITAT is the most tested device ever submitted to the FDA. Misinformation abounds when defamation is occurring. Peter Bodavitch, from Australia, is also under the jurisdiction of the US law enforcement and will be pursued also. Texas has even passed a regulation for funding for small companies, such as CAVITAT, to pursue adversaries who are illegally harassing and stalking, just as this unethical bunch of frauds has done and continues to do.

Contrary to stories posted of our demise and sinking under the waves, CAVITAT is stronger than ever and still in business. We have now completed the first of three buildings on our campus in Emory, Texas. Ground breaking on building two will commence June 1, 2008. CAVITAT has already delivered 4 units this month and is in the process of delivering 4 more overseas. We have finally broken into the dental schools with the first of 4 units delivered this year. This means all dental schools should follow suit. Our latest unit is a hit already despite the QW renderings and assault. THEY HAVE LOST THE WAR!!

As of January, over 540,000 patients have been safely scanned with the CAVITAT. We have never been, nor claimed to be, a diagnostic device. We have never made a diagnosis, but we have provided 540,000 patients with the images their medical professional needs to make a decision on what may be the cause of their illness, or an image that tells them their jawbone is healthy. When used adjunctive with an X-ray, the doctor is able to gather enough information to make an intelligent diagnosis. When using an X-ray alone, he or she can only be sure 27% of the time. In our estimation, every doctor that owns a CAVITAT and has not been intimidated from using this high technology device should have gross revenues of over $1,000,000 for the five years the CAVITAT has been in use. Did you receive your fair share, or did the QW intimidate you? If so, please write us and include a copy of any board action paperwork you have received. If they have attacked you for using the CAVITAT, we will take action, as the CAVITAT is 100% legal. Almost all board actions can be traced to the QW and or AETNA. We will take action where proof is provided.

CAVITAT is not the controversy, the QW is. Their alliance with the state boards is confirmation alone of conspiracy.